Bilateral Changes of Cannabinoid Receptor Type 2 Protein and mRNA in the Dorsal Root Ganglia of a Rat Neuropathic Pain Model

Journal of Histochemistry and Cytochemistry

Volumn 61, Issue 7, 2013, Pages 529-547

  Svíženská, Ivana Hradilová ^a,b   Brázda, Václav ^a,c   Klusáková, Ilona ^a,b   Dubový, Petr ^a,b  

^a CENTRAL EUROPEAN INSTITUTE OF TECHNOLOGY   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

^c INSTITUTE OF BIOPHYSICS   (Czech Republic)

Author keywords

remote neuroinflammation; satellite glial cells; unilateral nerve injury

Indexed keywords

CANNABINOID 2 RECEPTOR; MESSENGER RNA;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURVIVAL; CERVICAL SPINE; CONTROLLED STUDY; GLIA CELL; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUMBAR SPINE; MALE; NERVE FIBER; NERVOUS SYSTEM INFLAMMATION; NEUROPATHIC PAIN; NEUROPROTECTION; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; SCIATIC NERVE INJURY; SPINAL GANGLION; WESTERN BLOTTING; ANIMAL; ANIMAL BEHAVIOR; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; INJURY; METABOLISM; NEURALGIA; PATHOLOGY; REMOTE NEUROINFLAMMATION; SATELLITE GLIAL CELLS; SCIATIC NERVE; UNILATERAL NERVE INJURY; WISTAR RAT;

REMOTE NEUROINFLAMMATION; SATELLITE GLIAL CELLS; UNILATERAL NERVE INJURY;

ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; GANGLIA, SPINAL; GENE EXPRESSION REGULATION; NEURALGIA; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB2; RNA, MESSENGER; SCIATIC NERVE;

EID: 84882942975     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/0022155413491269     Document Type: Article

References (88)

1. Anand U,Otto WR,Sanchez-Herrera D,Facer P,Yiangou Y,Korchev Y,Birch R,Benham C,Bountra C,Chessell IP, et al.Cannabinoid receptor CB2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons.Pain. 2008;138:667-680.
2. Atwood BK,Mackie K.CB2: a cannabinoid receptor with an identity crisis. Br J Pharmacol. 2010;160:467-479.
3. Atwood BK,Straiker A,Mackie K.CB2 cannabinoid receptors inhibit synaptic transmission when expressed in cultured autaptic neurons.Neuropharmacology. 2012;63:514-523.
4. Austin PJ,Moalem-Taylor G.The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. J Neuroimmunol. 2010;229:26-50.
5. Beltramo M,Bernardini N,Bertorelli R,Campanella M,Nicolussi E,Fredduzzi S,Reggiani A.CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms. J Neurosci. 2006;23:1530-1538.
6. Bouaboula M,Desnoyer N,Carayon P,Combes T,Casellas P.Gi protein modulation induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2: implication for intracellular signalization cross-regulation. Mol Pharmacol. 1999;55:473-480.
7. Brázda V,Klusáková I,Svíženská I,Veselková Z,Dubový P.Bilateral changes in IL-6 protein, but not in its receptor gp130, in rat dorsal root ganglia following sciatic nerve ligature.Cell Mol Neurobiol. 2009;29:1053-1062.
8. Brázda V,Muller P,Brozkova K,Vojtesek B.Restoring wild-type conformation and DNA-binding activity of mutant p53 is insufficient for restoration of transcriptional activity.Biochem Biophys Res Commun. 2006;351:499-506.
9. Brooks JW,Thompson SW,Rice AS,Malcanqio M.(S)-AMPA inhibits electrically evoked calcitonin gene-related peptide (CGRP) release from the rat dorsal horn: reversal by cannabinoid receptor antagonist SR141716A.Neurosci Lett. 2004;372:85-88.
10. Brownjohn PW,Ashton JC.Novel targets in pain research: the case for CB2 receptors as a biorational pain target. Curr Anaesth Crit Care. 2009;20:198-203.
11. Burry RW.Specificity controls for immunocytochemical methods.J Histochem Cytochem. 2000;48:163-165.
12. Calignano A,La Rana G,Giuffrida A,Piomelli D.Control of pain initiation by endogenous cannabinoids.Nature. 1998;394:277-281.
13. Clark AK,Gentry C,Bradbury EJ,McMahon SB,Malcangio M.Role of spinal microglia in rat models of peripheral nerve injury and inflammation.Eur J Pain. 2007;11:223-230.
14. DeLeo JA,Yezierski RP. The role of neuroinflammation and neuroimmune activation in persistent pain. Pain. 2001:1-6.
15. Devor M,Seltzer ZTextbook of pain. 1999. Pathophysiology of damaged nerves in relation to chronic pain. In: WallPDMelzackR, editors. Textbook of pain, 4th ed.Edinburgh, UK: Churchill Livingstone. p. 129-164.Wall PDMelzack R, ed. Edinburgh, UK: Churchill Livingstone; 1999:129-164.
16. Dijkstra CD,Damoiseaux J.Macrophage heterogeneity established by immunocytochemistry.Prog Histochem Cytochem. 1993;27:1-65.
17. Dublin P,Hanani M.Satellite glial cells in sensory ganglia: their possible contribution to inflammatory pain. Brain Behav Immun. 2007;21:592-598.
18. Dubový P.Wallerian degeneration and peripheral nerve conditions for both axonal regeneration and neuropathic pain induction.Ann Anat. 2011;193:267-275.
19. Dubový P,Jančálek R,Klusáková I,Svíženská I,Pejchalova K.Intra- and extraneuronal changes of immunofluorescence staining for TNF-alpha and TNFR1 in the dorsal root ganglia of rat peripheral neuropathic pain models.Cell Mol Neurobiol. 2006;26:1205-1217.
20. Dubový P,Klusáková I,Svíženská I.A quantitative immunohistochemical study of the endoneurium in the rat dorsal and ventral spinal roots.Histochem Cell Biol. 2002;117:473-480.
21. Dubový P,Klusáková I,Svíženská I,Brázda V.Satellite glial cells express IL-6 and corresponding signal-transducing receptors in the dorsal root ganglia of rat neuropathic pain model.Neuron Glia Biol. 2010a;6:73-83.
22. Dubový P,Klusáková I,Svíženská I,Brázda V.Spatio-temporal changes of SDF1 and its CXCR4 receptor in the dorsal root ganglia following unilateral sciatic nerve injury as a model of neuropathic pain.Histochem Cell Biol. 2010b;133:323-337.
23. Dubový P,Tuckova L,Jančálek R,Svíženská I,Klusáková I.Increased invasion of ED-1 positive macrophages in both ipsi- and contralateral dorsal root ganglia following unilateral nerve injuries.Neurosci Lett. 2007;427:88-93.
24. Elson K,Simmons A,Speck P.Satellite cell proliferation in murine sensory ganglia in response to scarification of the skin.Glia. 2004;45:105-109.
25. Fernández-Ruiz J,González S,Romero J,Ramos JACannabinoids as therapeutics. Mechoulam R, ed. Basel, Switzerland: Birkhäuser Verlag; 2005:79-109.
26. Gao Y,Vasilyev DV,Goncalves MB,Howell FV,Hobbs C,Mechoulam R,Shen R,Zhang MY,Strassle BW,Lu P, et al.Loss of retrograde endocannabinoids signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice.J Neurosci. 2010;30:2017-2024.
27. Hanani M.Satellite glial cells in sensory ganglia: from form to function. Brain Res Brain Res Rev. 2005;48:457-476.
28. Hanuš L,Breuer A,Tchilibon S,Shiloah S,Goldenberg D,Horowitz M,Pertwee RG,Ross RA,Mechoulam R,Fride E.HU-308 a specific agonist for CB(2), a peripheral cannabinoid receptor.Proc Natl Acad Sci U S A. 1999;96:14228-14233.
29. Hargreaves K,Dubner R,Brown F,Flores C,Joris J.A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia.Pain. 1988;32:77-88.
30. Harnicarova A,Kozubek S,Pachernik J,Krejci J,Bartova E.Distinct nuclear arrangement of active and inactive c-myc genes in control and differentiated colon carcinoma cells.Exp Cell Res. 2006;312:4019-4035.
31. Hill CE,Harrison BJ,Rau KK,Hougland MT,Bunge MB,Mendell LM,Petruska JC.Skin incision induces expression of axonal regeneration-related genes in adult rat spinal sensory neurons.J Pain. 2010;11:1066-1073.
32. Hohmann AG,Martin WJ,Tsou K,Walker JM.Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2.Life Sci. 1995;56:2111-2118.
33. Hsieh GC,Pai M,Chandran P,Hooker BA,Zhu CZ,Salyers AK,Wensink EJ,Zhan CC,Carroll WA,Dart MJ, et al.Central and peripheral sites of action for CB2 receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats.Br J Pharmacol. 2011;162:428-440.
34. Hu P,Bembrick AL,Keay KA,McLachlan EM.Immune cell involvement in dorsal root ganglia and spinal cord after chronic constriction or transection of the rat sciatic nerve.Brain Behav Immun. 2007;21:599-616.
35. Hu P,McLachlan EM.Distinct functional types of macrophage in dorsal root ganglia and spinal nerves proximal to sciatic and spinal nerve transections in the rat.Exp Neurol. 2003;184:590-605.
36. Huang TY,Cherkas PS,Rosenthal DW,Hanani M.Dye coupling among satellite glial cells in mammalian dorsal root ganglia.Brain Res. 2005;1036:42-49.
37. Ibrahim MM,Deng H,Zvonok A,Cockayne DA,Kwan J,Mata HP,Vanderah TW,Lai J,Porreca F,Makriyannis A, et al.Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc Natl Acad Sci U S A. 2003;100:10529-10533.
38. Jacobs JM,Macfarlane RM,Cavanagh JB.Vascular leakage in the dorsal root ganglia of the rat, studied with horseradish peroxidase.J Neurol Sci. 1976;29:95-107.
39. Jančálek R,Dubový P,Svíženská I,Klusáková I.Bilateral changes of TNFalpha and IL-10 protein in the lumbar and cervical dorsal root ganglia following a unilateral chronic constriction injury of the sciatic nerve.J Neuroinflamm. 2010;7:11.
40. Jančálek R,Svíženská HI,Klusáková I,Dubový P.Bilateral changes of IL-10 protein in lumbar and cervical dorsal root ganglia following proximal and distal chronic constriction injury of peripheral nerve.Neurosci Lett. 2011;501:86-91.
41. Jasmin L,Vit J-P,Bhargava A,Ohara PT.Can satellite glial cells be therapeutic target for pain control?.Neuron Glia Biol. 2010;6:63-71.
42. Jean-Gilles L,Gran B,Constantinescu CS.Interaction between cytokines, cannabinoids and the nervous system.Immunobiology. 2010;215:606-610.
43. Kirita T,Takebayashi T,Mizuno S,Takeuchi H,Kobayashi T,Fukao M,Yamashita T,Tohse N.Electrophysiologic changes in dorsal root ganglion neurons and behavioral changes in a lumbar radiculopathy model.Spine. 2007;32:E65-E72.
44. Klein TW.Cannabinoid-based drugs as anti-inflammatory therapeutics.Nat Rev Immunol. 2005;5:400-411.
45. Kleinschnitz C,Brinkhoff J,Sommer C,Stoll G.Contralateral cytokine gene induction after peripheral nerve lesions: dependence on the mode of injury and NMDA receptor signaling. Mol Brain Res. 2005;136:23-28.
46. Klusáková I,Dubový P.Experimental models of peripheral neuropathic pain based on traumatic nerve injuries-an anatomical perspective.Ann Anat. 2009;191:248-259.
47. Koltzenburg M,Wall PD,McMahon SB.Does the right side know what the left is doing?.Trends Neurosci. 1999;22:122-127.
48. Levin ME,Jin JG,Ji RR,Tong J,Pomonis JD,Lavery DJ,Miller SW,Chiang LW.Complement activation in the peripheral nervous system following the spinal nerve ligation model of neuropathic pain.Pain. 2008;137:182-201.
49. Liu CN,Devor M,Waxman SG,Kocsis JD.Subthreshold oscillations induced by spinal nerve injury in dissociated muscle and cutaneous afferents of mouse DRG.J Neurophysiol. 2002;87:2009-2017.
50. Liu F-Y,Sun Y-N,Wang F-T,Li Q,Su L,Zhao Z-F,Meng X-L,Zhao H,Wu X,Sun Q, et al.Activation of satellite glial cells in lumbar dorsal root ganglia contributes to neuropathic pain after spinal nerve ligation.Brain Res. 2012;1427:65-77.
51. Lu X,Richardson PM.Inflammation near the nerve cell body enhances axonal regeneration. J.Neurosci. 1991;11:972-978.
52. Malan TP,Ibrahim MM,Deng H,Liu Q,Mata HP,Vanderah T,Porreca F,Makriyannis A.CB2 cannabinoid receptor-mediated peripheral antinociception.Pain. 2001;93:239-245.
53. Martin WJ,Hohmann AG,Walker JM.Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: correlation between electrophysiological and antinociceptive effects. J Neurosci. 1996;16:6601-6611.
54. Mellick RS,Cavanagh JB.Changes in blood vessel permeability during degeneration and regeneration in peripheral nerves.Brain. 1968;91:141-160.
55. Mitrirattanakul S,Ramakul N,Guerrero AV,Matsuka Y,Ono T,Iwase H,Mackie K,Faull KF,Spigelman I.Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain.Pain. 2006;126:102-114.
56. Moalem G,Tracey DJ.Immune and inflammatory mechanisms in neuropathic pain.Brain Res Rev. 2006;51:240-264.
57. Nachemson AK,Bennett GJ.Does pain damage spinal cord neurons? Transsynaptic degeneration in rat following a surgical incision.Neurosci Lett. 1993;162:78-80.
58. Ohara PT,Vit JP,Bhargava A,Romero M,Sundberg C,Charles AC,Jasmin L.Gliopathic pain: when satellite glial cells go bad. Neuroscientist. 2009;15:450-463.
59. Pertwee RG.Cannabinoid receptors and pain.Prog Neurobiol. 2001;63:569-611.
60. Pitcher GM,Ritchie J,Henry LJ.Nerve constriction in the rat: model of neuropathic, surgical and central pain. Pain. 1999;83:37-46.
61. Racz I,Nadal X,Alferink J,Baños JE,Rehnelt J,Martín M,Pintado B,Gutierrez-Adan A,Sanguino E,Manzanares J, et al.Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain.J Neurosci. 2008;28:12125-12135.
62. Richardson JD,Kilo S,Hargreaves KM.Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors.Pain. 1998;75:111-119.
63. Ross RA,Coutts AA,McFarlane SM,Anavi-Goffer S,Irving AJ,Pertwee RG,MacEwan DJ,Scott RH.Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception. Neuropharmacology. 2001;40:221-232.
64. Rotshenker S.Wallerian degeneration: the innate immune response to traumatic nerve injury.J Neuroinflammation. 2011;8:109.
65. Ruohonen S,Khademi M,Jagodic M,Taskinen H-S,Olsson T,Roytta M.Cytokine responses during chronic denervation.J Neuroinflamm. 2005;2:26.
66. Sagar DR,Kelly S,Millns PJ,O'Shaughnessey CT,Kendall DA,Chapman V.Inhibitory effects of CB1 receptor and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats.Eur J Neurosci. 2005;22:371-379.
67. Saňudo-Peňa MC,Romero J,Seale GE,Fernandez-Ruiz JJ,Walker JM.Activational role of cannabinoids on movement.Eur J Pharmacol. 2000;391:269-274.
68. Scholz J,Woolf CJ.The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci. 2007;10:1361-1368.
69. Scott DA,Wright CE,Angus JA.Evidence that CB-1 and CB-2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat.Pain. 2004;109:124-131.
70. Ständer S,Schmelz M,Metze D,Luger T,Rukwied R.Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin.J Dermatol Sci. 2005;38:177-188.
71. Taiwo YO,Bjerknes LK,Goetzl EJ,Levine JD.Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system.Neuroscience. 1989;32:577-580.
72. Taiwo YO,Levine JD.Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia.Neuroscience. 1991;44:131-135.
73. Takeda K,Muramatsu M,Chikuma T,Kato T.Effect of memantine on the levels of neuropeptides and microglial cells in the brain regions of rats with neuropathic pain.J Mol Neurosci. 2009;39:380-390.
74. Takeda M,Takahashi M,Matsumoto S.Contribution of the activation of satellite glia in sensory ganglia to pathological pain.Neurosci Biobehav Rev. 2009;33:784-792.
75. Takeda M,Tanimoto T,Kadoi J,Nasu M,Takahashi M,Kitagawa J,Matsumoto S.Enhanced excitability of nociceptive trigeminal ganglion neurons by satellite glial cytokine following peripheral inflammation.Pain. 2007;129:155-166.
76. Tanimura A,Yamazaki M,Hashimotodani Y,Uchigashima M,Kawata S,Abe M,Kita Y,Hashimoto K,Shimizu T,Watanabe M, et al.The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission.Neuron. 2010;65:320-327.
77. Tsou K,Lowitz KA,Hohmann AG,Martin WJ,Hathaway CB,Bereiter DA,Walker JM.Suppression of noxious stimulus-evoked expression of FOS protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist.Neuroscience. 1996;70:791-798.
78. Üçeyler N,Sommer C.Wallerian degeneration and neuropathic pain.Drug Discov Today Dis Mech. 2006;3:351-356.
79. Viscomi MT,Oddi S,Latini L,Bisicchia E,Maccarrone M,Molinari M.The endocannabinoid system: a new entry in remote cell death mechanisms. Exp Neurol. 2010;224:56-65.
80. Viscomi MT,Oddi S,Latini L,Pasquariello N,Florenzano F,Bernardi G,Molinari M,Maccarrone M.Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3 K/Akt pathway.J Neurosci. 2009;29:4564-4570.
81. Walczak J-S,Pichette V,Leblond F,Desbiens K,Beaulieu P.Behavioural, pharmacological and molecular characterization of the saphenous nerve partial ligation: a new model of neuropathic pain. Neuroscience. 2005;132:1093-1102.
82. Whiteside GT,Lee GP,Valenzano KJ.The role of the cannabinoid CB2 receptor in pain transmission and therapeutic potential of small molecule CB2 receptor agonists.Curr Med Chem. 2007;14:917-936.
83. Wilkerson JL,Gentry KR,Dengler EC,Wallace JA,Kerwin AA,Kuhn MN,Zvonok AM,Thakur GA,Makriyannis A,Milligan ED.Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal anti-inflammatory cytokine responses in neuropathic rats exhibiting relief from allodynia.Brain Behav. 2012;2:155-177.
84. Woolf CJ,Mannion RJ.Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet. 1999;353:1959-1964.
85. Wotherspoon G,Fox A,McIntyre P,Colley S,Bevan S,Winter J.Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons.Neuroscience. 2005;135:235-245.
86. Yamaguchi H,Ochi M,Mori R,Ryoke K,Yamamoto S,Iwata A,Uchio Y.Unilateral sciatic nerve injury stimulates contralateral nerve regeneration.Neuroreport. 1999;10:1359-1362.
87. Zamboni L,De Martino C.Buffered picric acid-formaldehyde-a new rapid fixative for electron microscopy.J Cell Biol. 1967;35:A148.
88. Zhang J,Hoffert C,Vu HK,Groblewski T,Ahmad S,O'Donnel D.Induction of CB2 receptor expression in the rat spinal cord neuropathic but not inflammatory chronic pain models.Eur J Neurosci. 2003;17:2750-2754.